Through innovation, collaboration, and people centered science, BioVie is creating new solutions enabling people to live healthier and better lives. People Centered Science.
BioVie is a purpose-based company.
We are developing a different approach, which focuses on what we believe to be the root cause of the disease - inflammation.
We are committed to developing novel therapies and exploring potential new pathways to help people suffering from Parkinson's.
Taking a new look at the physiology of ascites, we are engineering a potential new solution that combines existing chemistry, technology, and innovative application.
Ascites / Cirrhosis
Featuring Dr. Steven Arnold (Harvard Medical School and Massachusetts General Hospital) and BioVie's management for a discussion on inflammation and what to expect from the anticipated Phase 3 topline data readout.
This website contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that could cause BioVie’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements.